VFEND
Identification of Vfend
Please sign up for a free trial to see the description of this product.
Examples of the descriptions of OTHER drugs:
Lipitor 10 mg
Apo-Irbesartan 150 mg
Crestor 20 mg
Google image searchProduct monograph
Active ingredient
voriconazole, 200 MG
DIN: 02256479
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 12-NOV-2004
ATC:
- J02 — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J02A — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- J02AC — Triazole derivatives (ATC, ATC/DDD)
- J02AC03 — VORICONAZOLE (ATC/DDD)
Reference brand drug: Vfend
